Updated view of tars for psoriasis: what have we learned over the last decade?
- 10 April 2022
- journal article
- review article
- Published by Wiley in International Journal of Dermatology
- Vol. 62 (3) , 290-301
Abstract
Tars are one of the most effective, unknown, and oldest therapies for psoriasis. They include coal tar (CT) and biomass‐derived products. These treatments, particularly the CT, have proven to be cost‐effective with long remission times compared to other systemic or topical treatments. However, they have hardly evolved in recent years, as they are not well‐embraced by clinicians or patients because of concerns regarding cosmesis and safety. This review summarizes current knowledge about the chemical characterization, mechanism of action, toxicity, and clinical studies supporting the use of tars for psoriasis over the last decade. Trends within these above aspects are reviewed, and avenues of research are identified. CT is rich in polycyclic aromatic hydrocarbons, whereas biomass‐derived tars are rich in phenols. While the activation of the aryl hydrocarbon receptor is involved in the antipsoriatic effect of CT, the mechanism of action of biomass‐derived products remains to be elucidated. No conclusive evidence exists about the risk of cancer in psoriasis patients under CT treatment. Large, randomized, double‐blind, controlled clinical trials are necessary to promote the inclusion of tars as part of modern therapies for psoriasis.Keywords
Funding Information
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (759324)
This publication has 41 references indexed in Scilit:
- Effect of treatment with methotrexate and coal tar on adipokine levels and indices of insulin resistance and sensitivity in patients with psoriasis vulgarisJournal of the European Academy of Dermatology and Venereology, 2014
- Goeckerman regimen for management of psoriasis refractory to biologic therapy: The University of California San Francisco experienceJournal of the American Academy of Dermatology, 2013
- DNA adducts in skin biopsies and 1-hydroxypyrene in urine of psoriasis patients and healthy volunteers following treatment with coal tarToxicology Letters, 2012
- Novel stain‐free lecithinized coal tar formulation for psoriasisInternational Journal of Dermatology, 2011
- Comparison of clobetasol propionate cream plus coal tar vs. topical psoralen and solar ultraviolet A therapy in palmoplantar psoriasisClinical and Experimental Dermatology, 2011
- Results of Goeckerman Treatment for Psoriasis in Children: A 21-Year Retrospective ReviewPediatric Dermatology, 2010
- Topical tazarotene vs. coal tar in stable plaque psoriasisClinical and Experimental Dermatology, 2010
- No Increased Risk of Cancer after Coal Tar Treatment in Patients with Psoriasis or EczemaJournal of Investigative Dermatology, 2010
- Efficacy, safety, and cost of Goeckerman therapy compared with biologics in the treatment of moderate to severe psoriasisInternational Journal of Dermatology, 2009
- Further evidence of the safety of tar in the management of psoriasisBritish Journal of Dermatology, 1985